Friday, March 13, 2015 3:28:11 PM
As of the end of 2014, Par Pharma had more than 200 products in its pipeline, which included 115 Abbreviated New Drug Applications (ANDA) pending with the U.S. Food and Drug Administration (FDA). These represent $36.7 billion of combined annual sales for the corresponding branded products in 2014, including 32 potential first-to-file and six potential first-to-market opportunities.
In the filing, Par Pharma describes its segments:
Our company operates in two business segments, Par Pharmaceutical, which includes generic products marketed under Par Pharmaceutical and sterile products marketed under Par Sterile Products, LLC (“Par Sterile,” formerly known as JHP Pharmaceuticals, LLC), and Par Specialty Pharmaceuticals (“Par Specialty,” formerly known as Strativa Pharmaceuticals), which markets two branded products.
For 2014, Par Pharma had revenues of roughly $1.31 billion, with a compound annual revenue growth rate of 12.2%.
Par Pharma intends to use the net proceeds of this offering to repay indebtedness. It also intends to use the remainder of the net proceeds, if any, for working capital and other general corporate purpose including supporting strategic growth opportunities in the future.
Read more: Par Pharma Files for IPO - 24/7 Wall St. http://247wallst.com/healthcare-business/2015/03/13/par-pharma-files-for-ipo/#ixzz3UINhZVkO
Follow us: @247wallst on Twitter | 247wallst on Facebook
Recent IGXT News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 07:45:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:00:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/15/2024 04:15:15 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/08/2024 09:23:06 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/08/2024 09:18:26 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/08/2024 06:50:04 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM